DNA damage responses in cell cycle G2 phase and mitosis -: Tracking and targeting

被引:0
|
作者
Ree, Anne Hansen [1 ]
Stokke, Trond
Bratland, Ase
Patzke, Sebastian
Nome, Ragnhild V.
Folkvord, Sigurd
Meza-Zepeda, Leonardo A.
Flatmark, Kjersti
Fodstad, Oystein
Andersson, Yvonne
机构
[1] Norwegian Radium Hosp, Dept Tumor Biol, N-0310 Oslo, Norway
[2] Norwegian Radium Hosp, Dept Oncol, N-0310 Oslo, Norway
[3] Norwegian Radium Hosp, Dept Radiat Biol, N-0310 Oslo, Norway
[4] Norwegian Radium Hosp, Dept Immunol, N-0310 Oslo, Norway
[5] Norwegian Radium Hosp, Dept Surg Oncol, N-0310 Oslo, Norway
关键词
cell cycle; G(2) checkpoint; mitosis; molecular targeting; cervical carcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In order to determine temporal responses of cell cycle populations to DNA damage, a rational combination of cell cycle analyses is critical. Moreover, the targeting of cell cycle checkpoint responses may modify the cytotoxic effect of DNA damage. Materials and Methods: The characteristics of cell cycle populations (DNA Content, cell cycle transitioning of S phase cells and size of mitotic cell fraction within the total G(2)/M phase population) in HeLa cells exposed to ionizing radiation were analyzed using three individual flow cytometry-based assays. The potential radiosensitization from inhibiting DNA damage responses was assessed by the colony formation assay. Results: Irradiation resulted in an initial accumulation of S phase cells in G(2) phase, from which the arrested cells were subsequently released to enter mitosis. Upon drug inhibition of G(2) checkpoint signaling or mitotic progression, the cytotoxic effect of ionizing radiation on the HeLa cells was amplified. Conclusion: DNA damage-induced cell cycle responses, analyzed by selected cytometry assays and modified by specific targeting, might contribute to an understanding of how to improve radiotherapy outcome.
引用
收藏
页码:1909 / 1916
页数:8
相关论文
共 50 条
  • [31] Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis
    B G Gabrielli
    J M Clark
    A K McCormack
    K A O Ellem
    Oncogene, 1997, 15 : 749 - 758
  • [32] Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis
    Gabrielli, BG
    Clark, JM
    McCormack, AK
    Ellem, KAO
    ONCOGENE, 1997, 15 (07) : 749 - 758
  • [33] Base excision repair of ionizing radiation-induced DNA damage in G1 and G2 cell cycle phases
    M Ahmad Chaudhry
    Cancer Cell International, 7
  • [34] Base excision repair of ionizing radiation-induced DNA damage in G1 and G2 cell cycle phases
    Chaudhry, M. Ahmad
    CANCER CELL INTERNATIONAL, 2007, 7 (1)
  • [35] HISTONE PHOSPHORYLATION IN G2 AND MITOSIS
    GURLEY, LR
    WALTERS, RA
    TOBEY, RA
    FEDERATION PROCEEDINGS, 1973, 32 (03) : 587 - &
  • [36] Activity of the GR in G2 and mitosis
    Abel, GA
    Wochnik, GM
    Rüegg, J
    Rouyer, A
    Holsboer, F
    Rein, T
    MOLECULAR ENDOCRINOLOGY, 2002, 16 (06) : 1352 - 1366
  • [37] Activation of Akt/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage
    Kandel, ES
    Skeen, J
    Majewski, N
    Di Cristofano, A
    Pandolfi, PP
    Feliciano, CS
    Gartel, A
    Hay, N
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (22) : 7831 - 7841
  • [38] MORPHOMETRIC STUDY OF NUCLEOLAR ORGANIZERS OF BHK CELL CHROMOSOMES DURING G0 PHASE, G2 PHASE, AND MITOSIS
    ZATSEPINA, OV
    HOZAK, P
    BABADZHANYAN, DP
    CHENTSOV, YS
    MOLECULAR BIOLOGY, 1988, 22 (04) : 813 - 822
  • [39] DNA Ligase 1 is an essential mediator of sister chromatid telomere fusions in G2 cell cycle phase
    Liddiard, Kate
    Ruis, Brian
    Kan, Yinan
    Cleal, Kez
    Ashelford, Kevin E.
    Hendrickson, Eric A.
    Baird, Duncan M.
    NUCLEIC ACIDS RESEARCH, 2019, 47 (05) : 2402 - 2424
  • [40] Cell-type-specific role of CHK2 in mediating DNA damage-induced G2 cell cycle arrest
    van Jaarsveld, Marijn T. M.
    Deng, Difan
    Ordonez-Rueda, Diana
    Paulsen, Malte
    Wiemer, Erik A. C.
    Zi, Zhike
    ONCOGENESIS, 2020, 9 (03)